Stryker Corp Financials
Stryker Corp (SYK) reported $25.1B in revenue for fiscal year 2025, up 11.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stryker’s recent numbers show a high-gross-margin business converting growth into stronger cash flow despite heavier financing and tax drag.
Across the recent period, operating cash flow rose from$3.7B to$5.0B even as net margin moved lower. Because operating margin improved to19.5% while interest expense reached$582M , the weaker bottom-line percentage reflects financing and tax drag more than deterioration in the core operating engine, so reported earnings understated cash generation.
Gross margin stayed near
Over the recent period, goodwill rose from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stryker Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Stryker Corp has an operating margin of 19.5%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is up from 16.3% the prior year.
Stryker Corp's revenue grew 11.2% year-over-year to $25.1B, a solid pace of expansion. This earns a growth score of 67/100.
Stryker Corp has a moderate D/E ratio of 0.66. This balance of debt and equity financing earns a leverage score of 34/100.
Stryker Corp's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.
Stryker Corp converts 17.1% of revenue into free cash flow ($4.3B). This strong cash generation earns a score of 81/100.
Stryker Corp earns a strong 14.5% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is unchanged from the prior year.
Stryker Corp scores 4.71, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($130.4B) relative to total liabilities ($25.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Stryker Corp passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Stryker Corp generates $1.55 in operating cash flow ($5.0B OCF vs $3.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Stryker Corp earns $8.40 in operating income for every $1 of interest expense ($4.9B vs $582.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Stryker Corp generated $25.1B in revenue in fiscal year 2025. This represents an increase of 11.2% from the prior year.
Stryker Corp's EBITDA was $6.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.3% from the prior year.
Stryker Corp reported $3.2B in net income in fiscal year 2025. This represents an increase of 8.5% from the prior year.
Stryker Corp earned $8.40 per diluted share (EPS) in fiscal year 2025. This represents an increase of 8.2% from the prior year.
Cash & Balance Sheet
Stryker Corp generated $4.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 22.8% from the prior year.
Stryker Corp held $4.0B in cash against $14.9B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Stryker Corp's gross margin was 64.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. That is unchanged from the prior year.
Stryker Corp's operating margin was 19.5% in fiscal year 2025, reflecting core business profitability. This is up 3.1 percentage points from the prior year.
Stryker Corp's net profit margin was 12.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.3 percentage points from the prior year.
Stryker Corp's ROE was 14.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. That is unchanged from the prior year.
Capital Allocation
Stryker Corp invested $1.6B in research and development in fiscal year 2025. This represents an increase of 10.7% from the prior year.
Stryker Corp invested $761.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.8% from the prior year.
Not reported for fiscal year 2025.
SYK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.8B | $25.1B+11.2% | $22.6B+10.2% | $20.5B+11.1% | $18.4B+7.8% | $17.1B+19.2% | $14.4B-3.6% | $14.9B+9.4% | $13.6B+9.3% | $12.4B+9.9% | $11.3B+13.9% | $9.9B+2.8% | $9.7B+7.2% | $9.0B+4.2% | $8.7B+4.2% | $8.3B |
| Cost of Revenue | N/A | $9.1B+11.0% | $8.2B+9.6% | $7.4B+8.3% | $6.9B+11.9% | $6.1B+16.0% | $5.3B+2.0% | $5.2B+11.3% | $4.7B+9.4% | $4.3B+11.6% | $3.8B+14.3% | $3.3B+0.8% | $3.3B+10.6% | $3.0B+7.9% | $2.8B-1.1% | $2.8B |
| Gross Profit | $16.8B | $16.1B+11.3% | $14.4B+10.6% | $13.1B+12.8% | $11.6B+5.6% | $11.0B+21.1% | $9.1B-6.6% | $9.7B+8.5% | $8.9B+9.3% | $8.2B+9.0% | $7.5B+13.7% | $6.6B+3.9% | $6.4B+5.6% | $6.0B+2.4% | $5.9B+6.9% | $5.5B |
| R&D Expenses | N/A | $1.6B+10.7% | $1.5B+5.6% | $1.4B-4.5% | $1.5B+17.7% | $1.2B+25.5% | $984.0M+1.3% | $971.0M+12.6% | $862.0M+9.5% | $787.0M+10.1% | $715.0M+14.4% | $625.0M+1.8% | $614.0M+14.6% | $536.0M+13.8% | $471.0M+1.9% | $462.0M |
| SG&A Expenses | N/A | $8.7B+12.6% | $7.7B+8.1% | $7.1B+11.4% | $6.4B-0.6% | $6.4B+19.9% | $5.4B+0.1% | $5.4B+5.0% | $5.1B+12.0% | $4.6B+10.0% | $4.1B+14.6% | $3.6B+1.8% | $3.5B+2.3% | $3.5B+3.0% | $3.4B+6.9% | $3.1B |
| Operating Income | N/A | $4.9B+32.5% | $3.7B-5.1% | $3.9B+36.9% | $2.8B+9.9% | $2.6B+16.2% | $2.2B-18.1% | $2.7B+6.9% | $2.5B+10.4% | $2.3B+5.6% | $2.2B+16.9% | $1.9B+49.4% | $1.2B-0.8% | $1.3B-27.9% | $1.7B+3.3% | $1.7B |
| Interest Expense | N/A | $582.0M+47.0% | $396.0M+11.2% | $356.0M+5.6% | $337.0M0.0% | $337.0M+7.0% | $315.0M+9.8% | $287.0M+8.7% | $264.0M+6.9% | $247.0M+8.3% | $228.0M+111.1% | $108.0M-4.4% | $113.0M+36.1% | $83.0M+31.7% | $63.0M+12.5% | $56.0M |
| Income Tax | N/A | $1.3B+154.1% | $499.0M-1.8% | $508.0M+56.3% | $325.0M+13.2% | $287.0M-19.2% | $355.0M-25.9% | $479.0M+140.0% | -$1.2B-214.8% | $1.0B+280.7% | $274.0M-7.4% | $296.0M-54.1% | $645.0M+213.1% | $206.0M-49.4% | $407.0M+19.4% | $341.0M |
| Net Income | $3.7B | $3.2B+8.5% | $3.0B-5.4% | $3.2B+34.2% | $2.4B+18.3% | $2.0B+24.7% | $1.6B-23.2% | $2.1B-41.4% | $3.6B+248.3% | $1.0B-38.1% | $1.6B+14.5% | $1.4B+179.4% | $515.0M-48.8% | $1.0B-22.5% | $1.3B-3.5% | $1.3B |
| EPS (Diluted) | $9.65 | $8.40+8.2% | $7.76-5.9% | $8.25+33.7% | $6.17+18.4% | $5.21+24.0% | $4.20-23.4% | $5.48-41.3% | $9.34+248.5% | $2.68-38.4% | $4.35+15.1% | $3.78+182.1% | $1.34-49.0% | $2.63-22.4% | $3.39-1.7% | $3.45 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SYK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.8B+11.3% | $43.0B+7.7% | $39.9B+8.2% | $36.9B+6.5% | $34.6B+0.9% | $34.3B+13.8% | $30.2B+10.8% | $27.2B+22.7% | $22.2B+8.6% | $20.4B+26.0% | $16.2B-6.0% | $17.3B+12.1% | $15.4B+16.6% | $13.2B+8.7% | $12.1B |
| Current Assets | $14.8B-0.6% | $14.8B+18.6% | $12.5B+21.8% | $10.3B+2.6% | $10.0B+3.2% | $9.7B-12.2% | $11.1B+13.6% | $9.7B+21.8% | $8.0B+1.7% | $7.9B-1.0% | $7.9B-8.5% | $8.7B+4.2% | $8.3B+2.3% | $8.1B+13.1% | $7.2B |
| Cash & Equivalents | $4.0B+9.8% | $3.7B+22.9% | $3.0B+61.1% | $1.8B-37.4% | $2.9B0.0% | $2.9B-32.1% | $4.3B+19.9% | $3.6B+42.3% | $2.5B-23.3% | $3.3B-1.9% | $3.4B+88.2% | $1.8B+34.1% | $1.3B-4.0% | $1.4B+54.1% | $905.0M |
| Inventory | $5.3B+11.2% | $4.8B-1.4% | $4.8B+21.2% | $4.0B+20.5% | $3.3B-5.2% | $3.5B+17.2% | $3.0B+0.8% | $3.0B+19.9% | $2.5B+21.4% | $2.0B+23.9% | $1.6B+3.2% | $1.6B+11.7% | $1.4B+12.4% | $1.3B-1.4% | $1.3B |
| Accounts Receivable | $4.0B+1.3% | $4.0B+5.9% | $3.8B+5.6% | $3.6B+18.0% | $3.0B+11.9% | $2.7B-6.6% | $2.9B+24.1% | $2.3B+6.1% | $2.2B+11.7% | $2.0B+18.4% | $1.7B+5.7% | $1.6B+3.6% | $1.5B+6.2% | $1.4B+0.9% | $1.4B |
| Goodwill | $19.3B+21.7% | $15.9B+4.0% | $15.2B+2.4% | $14.9B+15.2% | $12.9B+1.1% | $12.8B+40.9% | $9.1B+5.9% | $8.6B+19.5% | $7.2B+12.8% | $6.4B+53.7% | $4.1B-1.2% | $4.2B+8.9% | $3.8B+79.5% | $2.1B+3.4% | $2.1B |
| Total Liabilities | $25.4B+13.8% | $22.3B+4.8% | $21.3B+5.2% | $20.3B+2.6% | $19.8B-7.0% | $21.2B+22.4% | $17.4B+12.0% | $15.5B+26.9% | $12.2B+12.2% | $10.9B+41.1% | $7.7B-11.0% | $8.7B+36.4% | $6.4B+37.8% | $4.6B+3.3% | $4.5B |
| Current Liabilities | $7.8B+2.3% | $7.6B-3.9% | $7.9B+25.7% | $6.3B+38.6% | $4.5B-9.8% | $5.0B+14.6% | $4.4B-8.5% | $4.8B+37.9% | $3.5B+10.7% | $3.1B-10.1% | $3.5B-21.5% | $4.5B+67.9% | $2.7B+41.6% | $1.9B+2.0% | $1.8B |
| Long-Term Debt | $14.9B+21.9% | $12.2B+11.8% | $10.9B-8.1% | $11.9B-4.9% | $12.5B-5.7% | $13.2B+29.3% | $10.2B+20.6% | $8.5B+28.8% | $6.6B-1.4% | $6.7B+107.0% | $3.2B-0.5% | $3.2B+18.5% | $2.7B+56.9% | $1.7B-0.3% | $1.8B |
| Total Equity | $22.4B+8.7% | $20.6B+11.0% | $18.6B+11.9% | $16.6B+11.7% | $14.9B+13.7% | $13.1B+2.2% | $12.8B+9.2% | $11.7B+17.7% | $10.0B+4.4% | $9.6B+12.2% | $8.5B-1.0% | $8.6B-5.0% | $9.0B+5.2% | $8.6B+11.9% | $7.7B |
| Retained Earnings | $20.5B+10.5% | $18.5B+10.5% | $16.8B+13.6% | $14.8B+9.5% | $13.5B+8.2% | $12.5B+6.1% | $11.7B+9.1% | $10.8B+19.8% | $9.0B+1.6% | $8.8B+13.5% | $7.8B+3.1% | $7.6B-0.8% | $7.6B+3.9% | $7.3B+13.2% | $6.5B |
SYK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.5B | $5.0B+18.9% | $4.2B+14.3% | $3.7B+41.4% | $2.6B-19.6% | $3.3B-0.4% | $3.3B+49.6% | $2.2B-16.1% | $2.6B+67.4% | $1.6B-18.6% | $1.9B+95.2% | $981.0M-44.9% | $1.8B-5.5% | $1.9B+13.8% | $1.7B+15.6% | $1.4B |
| Capital Expenditures | $823.0M | $761.0M+0.8% | $755.0M+31.3% | $575.0M-2.2% | $588.0M+12.0% | $525.0M+7.8% | $487.0M-25.0% | $649.0M+13.5% | $572.0M-4.3% | $598.0M+22.0% | $490.0M+81.5% | $270.0M+15.9% | $233.0M+19.5% | $195.0M-7.1% | $210.0M-7.1% | $226.0M |
| Free Cash Flow | $4.7B | $4.3B+22.8% | $3.5B+11.2% | $3.1B+54.0% | $2.0B-25.6% | $2.7B-1.9% | $2.8B+80.9% | $1.5B-24.3% | $2.0B+112.1% | $961.0M-32.6% | $1.4B+100.4% | $711.0M-54.1% | $1.5B-8.4% | $1.7B+16.9% | $1.4B+19.8% | $1.2B |
| Investing Cash Flow | -$1.4B | -$4.9B-62.2% | -$3.0B-211.9% | -$962.0M+67.1% | -$2.9B-240.4% | -$859.0M+81.7% | -$4.7B-223.1% | -$1.5B+49.1% | -$2.9B-77.1% | -$1.6B+61.5% | -$4.2B-314.3% | $2.0B+204.2% | -$1.9B+15.3% | -$2.2B-201.2% | -$736.0M+65.5% | -$2.1B |
| Financing Cash Flow | -$3.0B | $113.0M+121.5% | -$525.0M+67.1% | -$1.6B-112.8% | -$749.0M+68.3% | -$2.4B-21400.0% | -$11.0M-466.7% | $3.0M-99.8% | $1.3B+267.4% | -$794.0M-135.2% | $2.3B+284.6% | -$1.2B-294.4% | $629.0M+109.7% | $300.0M+166.8% | -$449.0M-178.9% | -$161.0M |
| Dividends Paid | $1.3B | $1.3B+5.3% | $1.2B+7.0% | $1.1B+8.4% | $1.1B+10.6% | $950.0M+10.1% | $863.0M+10.9% | $778.0M+10.7% | $703.0M+10.5% | $636.0M+12.0% | $568.0M+9.0% | $521.0M+12.8% | $462.0M+15.2% | $401.0M+23.8% | $324.0M+16.1% | $279.0M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $307.0M+2.3% | $300.0M+30.4% | $230.0M+1669.2% | $13.0M-98.1% | $700.0M+600.0% | $100.0M-68.5% | $317.0M+193.5% | $108.0M-82.6% | $622.0M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SYK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0%0.0pp | 63.9%+0.2pp | 63.7%+0.9pp | 62.8%-1.3pp | 64.1%+1.0pp | 63.1%-2.0pp | 65.1%-0.6pp | 65.7%0.0pp | 65.7%-0.5pp | 66.3%-0.1pp | 66.4%+0.7pp | 65.7%-1.0pp | 66.7%-1.2pp | 67.9%+1.7pp | 66.2% |
| Operating Margin | 19.5%+3.1pp | 16.3%-2.6pp | 19.0%+3.6pp | 15.4%+0.3pp | 15.1%-0.4pp | 15.5%-2.7pp | 18.2%-0.4pp | 18.6%+0.2pp | 18.5%-0.8pp | 19.2%+0.5pp | 18.7%+5.8pp | 12.9%-1.0pp | 13.9%-6.2pp | 20.1%-0.2pp | 20.3% |
| Net Margin | 12.9%-0.3pp | 13.3%-2.2pp | 15.4%+2.7pp | 12.8%+1.1pp | 11.7%+0.5pp | 11.1%-2.8pp | 14.0%-12.1pp | 26.1%+17.9pp | 8.2%-6.3pp | 14.5%+0.1pp | 14.5%+9.2pp | 5.3%-5.8pp | 11.2%-3.8pp | 15.0%-1.2pp | 16.2% |
| Return on Equity | 14.5%0.0pp | 14.5%-2.5pp | 17.0%+2.8pp | 14.2%+0.8pp | 13.4%+1.2pp | 12.2%-4.0pp | 16.3%-14.0pp | 30.3%+20.1pp | 10.2%-7.0pp | 17.3%+0.3pp | 16.9%+10.9pp | 6.0%-5.1pp | 11.1%-4.0pp | 15.1%-2.4pp | 17.5% |
| Return on Assets | 6.8%-0.2pp | 7.0%-1.0pp | 7.9%+1.5pp | 6.4%+0.6pp | 5.8%+1.1pp | 4.7%-2.2pp | 6.9%-6.2pp | 13.1%+8.5pp | 4.6%-3.5pp | 8.1%-0.8pp | 8.9%+5.9pp | 3.0%-3.5pp | 6.5%-3.3pp | 9.8%-1.2pp | 11.1% |
| Current Ratio | 1.89-0.1x | 1.95+0.4x | 1.580.0x | 1.63-0.6x | 2.20+0.3x | 1.93-0.6x | 2.51+0.5x | 2.02-0.3x | 2.29-0.2x | 2.50+0.2x | 2.27+0.3x | 1.95-1.2x | 3.14-1.2x | 4.34+0.4x | 3.92 |
| Debt-to-Equity | 0.66+0.1x | 0.590.0x | 0.59-0.1x | 0.71-0.1x | 0.84-0.2x | 1.01+0.2x | 0.80+0.1x | 0.72+0.1x | 0.660.0x | 0.70+0.3x | 0.380.0x | 0.38+0.1x | 0.30+0.1x | 0.200.0x | 0.23 |
| FCF Margin | 17.1%+1.6pp | 15.4%+0.1pp | 15.3%+4.3pp | 11.0%-5.0pp | 16.0%-3.4pp | 19.4%+9.1pp | 10.4%-4.6pp | 15.0%+7.3pp | 7.7%-4.9pp | 12.6%+5.4pp | 7.1%-8.9pp | 16.0%-2.7pp | 18.8%+2.0pp | 16.7%+2.2pp | 14.5% |
Similar Companies
Where Stryker Corp Ranks
Frequently Asked Questions
What is Stryker Corp's annual revenue?
Stryker Corp (SYK) reported $25.1B in total revenue for fiscal year 2025. This represents a 11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stryker Corp's revenue growing?
Stryker Corp (SYK) revenue grew by 11.2% year-over-year, from $22.6B to $25.1B in fiscal year 2025.
Is Stryker Corp profitable?
Yes, Stryker Corp (SYK) reported a net income of $3.2B in fiscal year 2025, with a net profit margin of 12.9%.
What is Stryker Corp's EBITDA?
Stryker Corp (SYK) had EBITDA of $6.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Stryker Corp have?
As of fiscal year 2025, Stryker Corp (SYK) had $4.0B in cash and equivalents against $14.9B in long-term debt.
What is Stryker Corp's gross margin?
Stryker Corp (SYK) had a gross margin of 64.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stryker Corp's operating margin?
Stryker Corp (SYK) had an operating margin of 19.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stryker Corp's net profit margin?
Stryker Corp (SYK) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stryker Corp's return on equity (ROE)?
Stryker Corp (SYK) has a return on equity of 14.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stryker Corp's free cash flow?
Stryker Corp (SYK) generated $4.3B in free cash flow during fiscal year 2025. This represents a 22.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stryker Corp's operating cash flow?
Stryker Corp (SYK) generated $5.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Stryker Corp's total assets?
Stryker Corp (SYK) had $47.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stryker Corp's capital expenditures?
Stryker Corp (SYK) invested $761.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Stryker Corp spend on research and development?
Stryker Corp (SYK) invested $1.6B in research and development during fiscal year 2025.
What is Stryker Corp's current ratio?
Stryker Corp (SYK) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.
What is Stryker Corp's debt-to-equity ratio?
Stryker Corp (SYK) had a debt-to-equity ratio of 0.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stryker Corp's return on assets (ROA)?
Stryker Corp (SYK) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stryker Corp's Altman Z-Score?
Stryker Corp (SYK) has an Altman Z-Score of 4.71, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Stryker Corp's Piotroski F-Score?
Stryker Corp (SYK) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stryker Corp's earnings high quality?
Stryker Corp (SYK) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Stryker Corp cover its interest payments?
Stryker Corp (SYK) has an interest coverage ratio of 8.40x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Stryker Corp?
Stryker Corp (SYK) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.